FORE Biotherapeutics has announced that its plixorafenib abstract has been selected for poster presentation at the highly ...

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...

NEW ORLEANS, La., May 7, 2025 /PRNewswire/ -- Mana.bio, a biotechnology company leveraging artificial intelligence (AI) and nanotechnology for targeted RNA delivery, today announced three poster ...

In addition to the $1,500 grand prize, called the Lea Rudee Outstanding Poster Award, judges selected one student presenter ...

Discover groundbreaking research and presentations from leading companies at the ARVO 2025 Annual Meeting, advancing ...

Upload a selfie (or any portrait) to ChatGPT and prompt it with the following: Turn my photo into a cartoon ava ...

He's developed images and visuals for North Texas musical giants Leon Bridges and Post Malone in addition to iconic brands, ...

Stories of personal connection to their work weren’t uncommon at the UB RENEW Institute’s spring poster session and ...

Cardiff Oncology has sufficient funds to operate until early 2027 but will face funding challenges by 2026. Learn why CRDF ...

Faculty and graduate students from the University of Wyoming College of Education showcased their work at the recent American Educational Research Association (AERA) annual meeting in Denver, Colo., ...

Digestive Disease Week (DDW) 2025: Abstract Number: Mo1549 Session Type: Poster Session Title: Cholelithiasis and Biliary Tract Disorders Date & Time: May 5, 2025 from 12:30 PM to 1:30 PM PDT ...

President Trump has rewritten the propaganda playbook for the modern political age. It’s one part Cold War witch hunt, one ...